Cell Line Development Market Intelligence Report - Global Forecast to 2027

Cell Line Development Market Intelligence Report - Global Forecast to 2027

The Global Cell Line Development Market is projected to reach USD 9,698.15 million by 2027 from USD 4,373.91 million in 2021, at a CAGR 14.19% during the forecast period.

Market Statistics:

The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

• The Americas Cell Line Development Market size was estimated at USD 1,568.30 million in 2021 and expected to reach USD 1,768.42 million in 2022, at a CAGR 13.77% to reach USD 3,402.33 million by 2027.
• The Asia-Pacific Cell Line Development Market size was estimated at USD 1,251.17 million in 2021 and expected to reach USD 1,444.27 million in 2022, at a CAGR 14.65% to reach USD 2,842.41 million by 2027.
• The Europe, Middle East & Africa Cell Line Development Market size was estimated at USD 1,554.44 million in 2021 and expected to reach USD 1,773.99 million in 2022, at a CAGR 14.22% to reach USD 3,453.40 million by 2027.

Market Segmentation & Coverage:

The report on cell line development identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. Our market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for your market plan.

This research report categorizes the cell line development to forecast the revenues and analyze the trends in each of the following sub-markets:

Type:

• Continuous Cell Lines
• Hybridomas
• Primary Cell Lines
• Recombinant Cell Lines

Source:

• Amphibian
• Insect
• Mammalian

Product:

• Equipment
  • Automated Systems
  • Bioreactors
  • Biosafety Cabinets
  • Cell Counters and Viability Systems
  • Centrifuges
  • Filtration Systems
  • Incubators
  • Microscopes
  • Storage Equipment
• Media and Reagents
  • Media
    • Minimum Essential Media
    • Reduced Serum Media
    • Serum-free Media
  • Reagents
    • Buffers and Chemicals
    • Cell Dissociation Reagents
    • Cryopreservative Reagents
    • Supplements and Growth Factors
  • Serum
    • Adult Bovine Serum
    • Fetal Bovine Serum

Application:

• Bioproduction
  • Diagnostics
  • Recombinant Protein Therapeutics
  • Vaccine Production
• Drug Discovery
  • Disease Modeling
  • Drug Screening and Development
  • Target Validation
• Research
• Tissue Engineering & Regenerative Medicine
• Toxicity Testing

Region:

• Americas
  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
    • California
    • Florida
    • Illinois
    • New York
    • Ohio
    • Pennsylvania
    • Texas
• Asia-Pacific
  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
• Europe, Middle East & Africa
  • France
  • Germany
  • Italy
  • Netherlands
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • United Arab Emirates
  • United Kingdom

Company Usability Profiles:

• AGC Biologics
• Aragen Bioscience, Inc.
• Boehringer Ingelheim International GmbH
• Catalent, Inc.
• Corning Incorporated
• EuBiologics Co.,Ltd.
• GE Healthcare
• Genscript Biotech
• Lonza Group AG
• Merck KGaA
• Rentschler Biopharma SE
• Samsung Biologics Co., Ltd.
• Sartorius AG
• Selexis SA
• Thermo Fisher Scientific Inc.
• Vista Biologicals Corporation
• WuXi AppTec

Currency: USD

Base Year: 2021

Estimated Year: 2022

Forecast Year: 2027

Base Year Value: USD 4,373.91 million

Estimated Year Value: USD 4,986.69 million

Forecast Year Value: USD 9,698.15 million

CAGR (%): 14.19%.

Please Note: PDF & Excel + Online Access - 1 Year